Cholecystokinin and panic disorder--three unsettled questions (Q34060773)

30 July 2017

1 reference

title

Cholecystokinin and panic disorder--three unsettled questions (English)

1 reference

30 July 2017

1 reference

1

Rehfeld JF

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

93

1 reference

30 July 2017

issue

1-3

1 reference

30 July 2017

page(s)

79-83

1 reference

New peptide in the vertebrate CNS reacting with antigastrin antibodies

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Identification of two related pentapeptides from the brain with potent opiate agonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Immunochemical evidence of cholecystokinin-like peptides in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Cholecystokinin and its COOH-terminal octapeptide in the pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Localisation of gastrins to neuro- and adenohypophysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Progastrin and its products in the cerebellum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Neuronal cholecystokinin: one or multiple transmitters?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Effect of gastrin and its C-terminal tetrapeptide on insulin secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Pentagastrin has panic-inducing properties in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

The cholecystokinin hypothesis of panic and anxiety disorders: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Biological actions of cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Cholecystokinin in anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Brain circuits in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Structure–Function Relationships in the Active C-Terminal Tetrapeptide Sequence of Gastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Expression cloning and characterization of the canine parietal cell gastrin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Comparative distribution of cholecystokinin and other neuropeptides. Why is this peptide different from all other peptides?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Gastrin and cholecystokinin in human cerebrospinal fluid. Immunochemical determination of concentrations and molecular heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Cholecystokinin and neurotensin gradients in human CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Increased cerebrospinal fluid concentrations of C- but not N-terminal cholecystokinin fragments in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Cholecystokinin peptides in cerebrospinal fluid: a study in healthy male subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

Cerebrospinal fluid cholecystokinin, bombesin and somatostatin in schizophrenia and normals

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900179-8

7 January 2021

10.1016/S0167-0115(00)00179-8

Identifiers

DOI

1 reference

30 July 2017

1 reference